Global Alliance for TB Drug Development Receives Pledge of up to $40 Million from USAID
The Global Alliance for TB Drug Development (TB Alliance), a public-private product-development partnership leading the development of new and afforda...
News Center
Global Alliance for TB Drug Development Appoints Respected Scientist and Director of R&D as New Chief Executive
Dr. Melvin Spigelman, TB Alliance Director of Research and Development, to Lead Organization in Speeding Search for Faster, Better CureThe Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development...
XDR-TB photographs to be displayed globally
A collection of photos depicting the reality of extremely drug-resistant tuberculosis (XDR-TB) was unveiled at a kick-off event Friday, October 3rd in...
10/06/2008Continue Reading >
TB Alliance Appoints First Chief Administrative Officer
Healthcare Executive Colleen Pero to Guide Growth of World’s Leading TB Drug Development OrganizationThe Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and developme...
In Pursuit of Better Weapons to Combat TB
Tuberculosis remains a stubborn foe despite the efforts of the public and private sector's efforts to deploy new antibiotics and diagnostic tool...
Trench Warfare in a Battle With TB
TOMSK, RUSSIA--Six mornings a week, nurse Galina Kruchinina circles this Siberian city with a black medicine bag. She's hunting for people infec...
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development Announce Five-Year Collaboration Targeted to Accelerate TB Treatment R&D
The NITD and the TB Alliance’s collaboration aims to move projects quickly from the research phase through the translational stage and into developmentThe Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a five-year resear...
Drugs, Industry, and Academia
This week, international academic and industry leaders, investors, and policy-makers participated in the Biotechnology Industry Organization's I...
Global Leaders Call for Integrated Approach to Treating TB and HIV
The first HIV-TB Global Leaders' Forum was held at the United Nations on Monday June 9, 2008, marking the first time world leaders, senior polit...
6/12/2008Continue Reading >
Tackling the new tuberculosis
Trials of the first new tuberculosis drug for 40 years are under way in South Africa. Scientists are looking for new compounds to help fight the inf...
News Center Search
Press Contact: press@tballiance.org
TB Alliance Publications
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
New TB Regimens: What Countries Want
Pathway to Patients
Policy on the Compassionate / Emergency Use of Experimental TB Alliance Drugs
TB In The News
Site by Darby Communications
© 2013 Global Alliance for TB Drug Development